https://www.avient.com/products/polymer-additives/foaming-agents
Gravi-Tech™ BIO Bio-Based Formulations
Mevopur™ Bio-based Polymer Solutions
CORE™ Bio-based Vinyl Plastisols
https://www.avient.com/products/polymer-additives/electrical-performance-additives
Gravi-Tech™ BIO Bio-Based Formulations
Mevopur™ Bio-based Polymer Solutions
CORE™ Bio-based Vinyl Plastisols
https://www.avient.com/products/polymer-additives/uv-and-light-blocking-additives
Gravi-Tech™ BIO Bio-Based Formulations
Mevopur™ Bio-based Polymer Solutions
CORE™ Bio-based Vinyl Plastisols
https://www.avient.com/products/polymer-additives/chain-extender-additives
Gravi-Tech™ BIO Bio-Based Formulations
Mevopur™ Bio-based Polymer Solutions
CORE™ Bio-based Vinyl Plastisols
https://www.avient.com/products/polymer-additives/reheat-additives-pet
Gravi-Tech™ BIO Bio-Based Formulations
Mevopur™ Bio-based Polymer Solutions
CORE™ Bio-based Vinyl Plastisols
https://www.avient.com/products/polymer-additives/repellant-antimicrobial-additives
Gravi-Tech™ BIO Bio-Based Formulations
Mevopur™ Bio-based Polymer Solutions
CORE™ Bio-based Vinyl Plastisols
https://www.avient.com/products/polymer-additives/surface-modifier-additives
Gravi-Tech™ BIO Bio-Based Formulations
Mevopur™ Bio-based Polymer Solutions
CORE™ Bio-based Vinyl Plastisols
https://www.avient.com/products/polymer-colorants/color-additive-combination-masterbatches
Gravi-Tech™ BIO Bio-Based Formulations
Mevopur™ Bio-based Polymer Solutions
CORE™ Bio-based Vinyl Plastisols
https://www.avient.com/investor-center/news/avient-announces-record-second-quarter-2021-results-increases-full-year-guidance
a market leader in sustainable, water-based inks technology for the textile screen printing industry.
operating results due to the potential variability across periods based on timing, frequency and magnitude.
Share-based compensation expense
https://www.avient.com/investor-center/news/polyone-announces-third-quarter-2017-results
Revenue increased 10% to $818 million, driven by broad-based organic growth of 5% and recent specialty acquisitions
operating results due to the potential variability across periods based on timing, frequency and magnitude.
Share-based compensation expense